PriceTargets.com logo

CareTrust REIT - CTRE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $42.80
  • Forecasted Upside: 9.08%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 3 Strong Buy Ratings
$39.24 As of 03/19/2026 04:59 PM ET
▼ -0.673 (-1.69%)

This chart shows the closing price for CTRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CareTrust REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTRE

Analyst Price Target is $42.80
▲ +9.08% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for CareTrust REIT in the last 3 months. The average price target is $42.80, with a high forecast of $48.00 and a low forecast of $39.00. The average price target represents a 9.08% upside from the last price of $39.24.

This chart shows the closing price for CTRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 11 investment analysts is to buy stock in CareTrust REIT. This rating has held steady since January 2026, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/24/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/24/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
6/22/2025
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
9/20/2025
  • 3 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
12/19/2025
  • 3 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
2/17/2026
  • 3 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2026

Latest Recommendations

  • 3 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/24/2026Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$41.00 ➝ $44.00
2/18/2026UBS GroupBoost TargetBuy ➝ Buy$44.00 ➝ $48.00
2/17/2026Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$37.00 ➝ $42.00
1/26/2026Weiss RatingsUpgradeBuy (B+) ➝ Buy (A-)
1/22/2026CitigroupInitiated CoverageMarket Outperform
1/22/2026The Goldman Sachs GroupSet Target$44.00
1/22/2026Citizens JmpUpgradeStrong-Buy
1/22/2026Citizens JmpInitiated CoverageMarket Outperform$44.00
1/12/2026Weiss RatingsDowngradeBuy (A-) ➝ Buy (B+)
1/9/2026BMO Capital MarketsUpgradeHold ➝ Outperform$43.00
1/8/2026UBS GroupBoost TargetBuy ➝ Buy$42.00 ➝ $43.00
12/29/2025Weiss RatingsReiterated RatingBuy (A-) ➝ Buy (A-)
12/22/2025Weiss RatingsReiterated RatingBuy (A-) ➝ Buy (A-)
12/15/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$41.00 ➝ $43.00
12/15/2025Weiss RatingsReiterated RatingBuy (A-) ➝ Buy (A-)
12/8/2025Weiss RatingsUpgradeBuy (B+) ➝ Buy (A-)
12/4/2025KeyCorpBoost TargetOverweight ➝ Overweight$36.00 ➝ $40.00
12/1/2025Weiss RatingsReiterated RatingBuy (B+) ➝ Buy (B+)
11/25/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$38.00 ➝ $41.00
11/19/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/18/2025UBS GroupUpgradeStrong-Buy
11/18/2025UBS GroupInitiated CoverageBuy$42.00
11/10/2025Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$36.00 ➝ $41.00
10/8/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
10/1/2025Cantor FitzgeraldInitiated CoverageNeutral$37.00
10/1/2025Cantor FitzgeraldUpgradeHold
9/27/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
9/2/2025Raymond James FinancialSet TargetStrong-Buy ➝ Strong-Buy$39.00
8/27/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$32.00 ➝ $38.00
8/14/2025KeyCorpBoost TargetOverweight ➝ Overweight$33.00 ➝ $36.00
8/11/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform
6/2/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$31.00 ➝ $32.00
3/14/2025WedbushReiterated RatingUnderperform ➝ Underperform$26.00 ➝ $26.00
3/13/2025Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$31.00
3/10/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$34.00 ➝ $31.00
2/21/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$37.00 ➝ $32.00
1/2/2025WedbushDowngradeNeutral ➝ Underperform$34.00 ➝ $26.00
12/9/2024BMO Capital MarketsDowngradeOutperform ➝ Market Perform$34.00 ➝ $32.00
10/7/2024KeyCorpBoost TargetOverweight ➝ Overweight$27.00 ➝ $34.00
10/7/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$33.00 ➝ $34.00
10/1/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$28.00 ➝ $34.00
8/22/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$27.00 ➝ $31.00
7/1/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$23.00 ➝ $27.00
5/30/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$24.00 ➝ $26.00
5/29/2024WedbushInitiated CoverageNeutral$26.00
5/9/2024KeyCorpBoost TargetOverweight ➝ Overweight$25.00 ➝ $27.00
1/31/2024Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$25.00 ➝ $24.00
1/30/2024Deutsche Bank AktiengesellschaftInitiated CoverageHold$23.00
1/5/2024KeyCorpBoost TargetOverweight ➝ Overweight$22.00 ➝ $25.00
11/27/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$22.00 ➝ $23.00
9/20/2023Jefferies Financial GroupInitiated CoverageBuy$23.00
9/11/2023Royal Bank Of CanadaUpgradeSector Perform ➝ Outperform$19.00 ➝ $23.00
8/16/2023BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$23.50 ➝ $24.00
7/27/2023Berenberg BankInitiated CoverageBuy$23.00
4/19/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$21.00
2/14/2023KeyCorpBoost TargetOverweight$21.00 ➝ $22.00
11/1/2022Raymond James FinancialLower TargetStrong-Buy$23.00 ➝ $22.00
10/21/2022BarclaysLower TargetEqual Weight$20.00 ➝ $19.00
8/8/2022BarclaysBoost Target$17.00 ➝ $20.00
7/7/2022KeyCorpLower TargetOverweight$23.00 ➝ $21.00
6/3/2022Capital One FinancialInitiated CoverageEqual Weight ➝ Equal Weight$21.50
4/18/2022BarclaysDowngradeOverweight ➝ Equal Weight$22.00 ➝ $17.00
3/18/2022Raymond James FinancialLower TargetStrong-Buy$27.00 ➝ $23.00
3/11/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$20.00
2/22/2022BarclaysLower Target$26.00 ➝ $22.00
2/1/2022Credit Suisse GroupInitiated CoverageNeutral$22.00
12/7/2021BMO Capital MarketsReiterated RatingBuy$25.00
11/18/2021Royal Bank Of CanadaLower TargetSector Perform$24.00 ➝ $22.00
10/7/2021Robert W. BairdInitiated CoverageOutperform$23.00
8/11/2021Royal Bank Of CanadaDowngradeOutperform ➝ Sector Perform
5/24/2021Royal Bank Of CanadaBoost TargetOutperform$24.00 ➝ $26.00
(Data available from 3/19/2021 forward)

News Sentiment Rating

1.27 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/21/2025
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2025
  • 5 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/20/2025
  • 4 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/19/2025
  • 1 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/19/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/18/2026
  • 7 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/17/2026
  • 36 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/19/2026

Current Sentiment

  • 36 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

CareTrust REIT

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.
Read More

Today's Range

Now: $39.24
Low: $39.08
High: $40.29

50 Day Range

MA: $38.78
Low: $36.10
High: $41.14

52 Week Range

Now: $39.24
Low: $25.82
High: $41.72

Volume

1,772,857 shs

Average Volume

1,882,603 shs

Market Capitalization

$8.76 billion

P/E Ratio

25.31

Dividend Yield

3.37%

Beta

0.74

Frequently Asked Questions

What sell-side analysts currently cover shares of CareTrust REIT?

The following Wall Street sell-side analysts have issued reports on CareTrust REIT in the last twelve months: BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Citizens Jmp, Jefferies Financial Group Inc., KeyCorp, Raymond James Financial, Inc., Royal Bank Of Canada, The Goldman Sachs Group, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, and Wells Fargo & Company.
View the latest analyst ratings for CTRE.

What is the current price target for CareTrust REIT?

0 Wall Street analysts have set twelve-month price targets for CareTrust REIT in the last year. Their average twelve-month price target is $42.80, suggesting a possible upside of 9.1%. UBS Group AG has the highest price target set, predicting CTRE will reach $48.00 in the next twelve months. Raymond James Financial, Inc. has the lowest price target set, forecasting a price of $39.00 for CareTrust REIT in the next year.
View the latest price targets for CTRE.

What is the current consensus analyst rating for CareTrust REIT?

CareTrust REIT currently has 1 hold rating, 7 buy ratings and 3 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CTRE will outperform the market and that investors should add to their positions of CareTrust REIT.
View the latest ratings for CTRE.

What other companies compete with CareTrust REIT?

Other companies that are similar to CareTrust REIT include Sabra Healthcare REIT, LTC Properties, National Health Investors, Omega Healthcare Investors and Ventas. Learn More about companies similar to CareTrust REIT.

How do I contact CareTrust REIT's investor relations team?

CareTrust REIT's physical mailing address is 905 CALLE AMANECER, SUITE 300, SAN CLEMENTE, CA, 92673. The company's listed phone number is (949) 542-3140 and its investor relations email address is [email protected]. The official website for CareTrust REIT is caretrustreit.com. Learn More about contacing CareTrust REIT investor relations.